Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Deccan Health Care Ltd

DECCAN
BSE
12.81
5.00%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Deccan Health Care Ltd

DECCAN
BSE
12.81
5.00%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
32Cr
Close
Close Price
12.81
Industry
Industry
Food - Processing - Others
PE
Price To Earnings
13.77
PS
Price To Sales
0.39
Revenue
Revenue
82Cr
Rev Gr TTM
Revenue Growth TTM
16.22%
PAT Gr TTM
PAT Growth TTM
95.69%
Peer Comparison
How does DECCAN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
DECCAN
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
161117151615192021222117
Growth YoY
Revenue Growth YoY%
28.446.077.30.734.29.533.229.947.013.7-14.9
Expenses
ExpensesCr
151016141514182020212016
Operating Profit
Operating ProfitCr
111111111122
OPM
OPM%
4.77.16.08.04.35.75.82.92.93.48.09.9
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
001100100011
Tax
TaxCr
000000000000
PAT
PATCr
001100100011
Growth YoY
PAT Growth YoY%
50.080.0215.2-51.920.0-1.9-73.6-7.7-33.371.7614.3
NPM
NPM%
1.72.73.13.50.82.42.80.70.61.14.35.8
EPS
EPS
0.20.20.30.30.10.20.30.10.10.10.40.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
343345607582
Growth
Revenue Growth%
-1.835.732.725.78.8
Expenses
ExpensesCr
322843567277
Operating Profit
Operating ProfitCr
252435
OPM
OPM%
6.016.14.46.34.25.9
Other Income
Other IncomeCr
0-30000
Interest Expense
Interest ExpenseCr
000000
Depreciation
DepreciationCr
111111
PBT
PBTCr
110223
Tax
TaxCr
000101
PAT
PATCr
000112
Growth
PAT Growth%
-17.3-5.1387.6-22.495.9
NPM
NPM%
1.11.00.72.51.52.8
EPS
EPS
0.30.20.20.80.50.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
161617202325
Reserves
ReservesCr
616165758284
Current Liabilities
Current LiabilitiesCr
13101281626
Non Current Liabilities
Non Current LiabilitiesCr
333433
Total Liabilities
Total LiabilitiesCr
929197108125138
Current Assets
Current AssetsCr
66687688106120
Non Current Assets
Non Current AssetsCr
262321201918
Total Assets
Total AssetsCr
929197108125138

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0-1-7-13-6
Investing Cash Flow
Investing Cash FlowCr
00000
Financing Cash Flow
Financing Cash FlowCr
005148
Net Cash Flow
Net Cash FlowCr
0-1-111
Free Cash Flow
Free Cash FlowCr
0-1-7-13-7
CFO To PAT
CFO To PAT%
56.3-177.6-2,210.0-840.9-554.7
CFO To EBITDA
CFO To EBITDA%
10.8-10.7-344.8-334.6-204.0

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4656475640
Price To Earnings
Price To Earnings
117.6170.2152.837.834.6
Price To Sales
Price To Sales
1.41.71.00.90.5
Price To Book
Price To Book
0.60.70.60.60.4
EV To EBITDA
EV To EBITDA
21.410.224.014.811.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.456.844.537.336.7
OPM
OPM%
6.016.14.46.34.2
NPM
NPM%
1.11.00.72.51.5
ROCE
ROCE%
0.80.90.72.41.6
ROE
ROE%
0.50.40.41.61.1
ROA
ROA%
0.40.40.31.40.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Deccan Health Care Limited (BSE: 542248), established in 1996, is a leading Indian fast-moving consumer wellness company specializing in science-backed nutraceuticals, preventive healthcare, and nutrition-led solutions. The company is purpose-driven, focusing on combating public health challenges—particularly iron deficiency and anemia—through accessible, culturally appropriate, and food-based interventions. With an integrated business model spanning R&D, manufacturing, branding, and distribution, DHCL operates across nutraceuticals, Ayurvedic, personal care, self-care, and NutriFoods segments. --- ### **Core Focus & Mission** - **Mission:** To help consumers age gracefully, improve overall well-being, and prevent disease through innovative, natural, and scientifically validated wellness solutions. - **Strategic Focus:** Inclusive health and wellness in rural India; affordable, high-quality nutrition; and preventive healthcare through dietary supplementation and lifestyle integration. - **Public Health Alignment:** Active contributor to the Government of India’s **Anemia Mukt Bharat (AMB)** initiative, aiming to reduce anemia in women, children, and adolescents through scalable, food-based iron delivery. --- ### **Business Model & Operations** #### **1. Integrated Value Chain Control** DHCL maintains full control across: - R&D (Innovation Hub in SIDCUL, Pantnagar, Uttarakhand) - Manufacturing - Branding (Nutridecc®, Organowild®, BE YOUNG, STAY YOUNG) - Distribution (e-commerce, B2B, exports) #### **2. Manufacturing Capabilities** - **Facility:** 3,536 sq. m. GMP- and WHO-GMP-compliant manufacturing plant at SIDCUL, Pantnagar, Uttarakhand (established 2010). - **Certifications:** ISO 9001:2015, FSSAI-licensed, compliant with DSHEA (USA) and Indian regulations. - **Production Capacity (Monthly):** - 456.25 million softgels - 1,216.67 million hardgels - 608,333 units of liquid orals - 243.33 million tablets - 212,916 units of external preparations - **Dosage Forms:** Tablets, capsules, softgels, liquids, syrups, powders, creams, lotions, and specialized formulations. - **Upcoming Expansion:** A new intermediary factory and upgraded packaging facilities are under development to meet rising demand. --- ### **Product Portfolio & Innovation** - **Total Market-Ready Products:** 1,500+ - **Active SKUs:** 400+ - **In Development:** 173 new recipes/formulations - **Key Brands:** - **Nutridecc®:** Science-based, lifestyle-focused supplements targeting modern health issues (e.g., Digital Eye Strain, Brain Fog, Tech Neck, Burnout). - **Organowild®:** Nutri-food and wellness line emphasizing organic, sustainable, and culturally resonant products (e.g., millet cookies, iron-enriched fruit bars). - **BE YOUNG & STAY YOUNG:** E-commerce-driven brands, with BE YOUNG focused on Indian consumers and STAY YOUNG for international markets. #### **Flagship Innovations (2023–2025)** | Product | Launch Date | Key Features | |--------|-------------|-------------| | **Iron-Enriched Fruit Bar** | 2023–24 | Palatable, non-medicinal iron solution with high compliance, no GI side effects; used in AMB programs. | | **Organowild Millet Cookies** | Dec 2023 | High-protein, nutrient-dense snacks aligned with International Year of Millets and eco-conscious trends. | | **Organowild Natural Iron Mango Slice** | May 2024 | Tasty, bioavailable iron delivery for adolescents and women; strong market acceptance and regional expansion. | | **7 Tulsi™ Extracts in Honey** | Aug 2020 | Immunity-boosting, easy-consumption product launched during the pandemic. | - **Scientific Backing:** Products are developed using advanced technology licensed from **CSIR-IHBT**, with validation from WHO- and ICMR-approved tools (e.g., digital hemoglobinometers). - **R&D Focus Areas:** Gut microbiome health, personalized nutrition, preventive micronutrients (Vitamins C/D, Omega-3s), and early-life nutrition. --- ### **Channels & Market Reach** #### **1. E-Commerce & Direct-to-Consumer (D2C)** - **Primary Platform:** [www.beyoungstore.com](http://www.beyoungstore.com) – hybrid B2B/B2C digital commerce platform. - **Operations:** Manages end-to-end supply chain via **Home Shops** and **Wellness Consultants**. - **Network (FY24):** 423+ wellness consultants, 23 home shops, serving 275,000+ consumers. - **States Covered:** Rajasthan, Punjab, UP, Bihar, Jharkhand, Assam, Mizoram, Odisha, Maharashtra, Gujarat, Telangana, and expanding. - **Digitization Goals:** Geotagging home shops, handheld sales devices, AI-driven demand-responsive supply chain. #### **2. Branded Distribution** - **Platforms:** Amazon, [www.otcfirst.in](http://www.otcfirst.in), and other online marketplaces. - **Target:** Health-conscious, premium wellness consumers in Tier 1–3 cities. #### **3. Private Label Manufacturing** - **Clients:** House of Masaba (Lovechild), Modicare, Plus Plus Lifesciences, MRL Pharma, Pranasa Mediworld, Quora Pharmaceuticals. - **Revenue Streams:** Commission, brokerage, and bulk manufacturing. #### **4. Exports & International Expansion** - **Current Export Markets:** Kenya, Nepal - **Registration in Progress:** Nigeria, UAE, USA - **Subsidiaries:** - **DBL USA:** To distribute in USA, Canada, South America ($5M phased investment planned). - **UAE Subsidiary:** In development for local inventory and sales. - **Future Targets:** GCC, Africa, and North America. --- ### **Strategic Priorities (2024–2025)** 1. **Expand Export Markets & Strengthen Global Footprint** 2. **Deepen Domestic Penetration** in underserved and rural areas 3. **Scale Clinically Validated Products** with proven efficacy 4. **Enhance E-Commerce & Omnichannel Capabilities** 5. **Invest in Innovation & Personalized Nutrition** (AI, chatbot-based recommendations, data analytics) 6. **Support National Health Initiatives** (e.g., Anemia Mukt Bharat) --- ### **Key Initiatives & Collaborations** - **Anemia Mukt Bharat Program:** - Supplying iron-fortified products (e.g., Iron Mango Bars) to 600 schoolgirls in Telangana. - Partnering with NGOs and government bodies. - **Project BeYoungBharat:** D2C outreach program successfully launched (FY22–23) with home shop expansion and localized delivery. - **Digital Health Tools:** Free chatbot on Nutridecc® website offering personalized nutrition advice for digital fatigue, burnout, and stress. --- ### **Corporate Leadership** - **Dr. Minto Purshotam Gupta** – Founder, Promoter, Chairman & Managing Director - PhD in Microbiology, Cellular Biochemistry (University of Mumbai) - Over 25 years in nutraceuticals and preventive healthcare - Former roles: Rallis India (TATA), Ranbaxy, SOL Pharmaceuticals, ICICI Bank, Idemitsu Kosan - Developed 1,600+ nutraceutical recipes; delivered over 100 crore consumer doses - **Meenakshi Gupta** – Promoter & Non-Executive Director - Master’s in Science in Education Extension - WHO-affiliated research in 1982; designed indigenous water filter --- ### **Financial & Operational Highlights** - **Revenue (Apr 2022–Mar 2023):** - ₹640.73 million from Beyoung Store (proprietorship) - ₹613.08 million in commission/brokerage - ₹0.62 million from international operations (Nepal) - **Cost Efficiency:** Material and operating expenses at ~30% of revenue; strong cost control and pricing power. - **Influencer Network:** ~463 active influencers (out of 600+ total pool); 10–15% traction rate; commission-based model. - **Consumer Base:** Over 275,000 served via e-commerce; 6,000+ Product Information Personnel (PIPs) trained. --- ### **Sustainability & Innovation** - **Sustainable Sourcing:** Organic and conventional raw materials; farm-to-factory supply chain. - **Sustainable Formats:** Millet-based, plant-forward, low-waste packaging (sachets, stick packs, pouches, customizable options). - **Environmental Compliance:** Effluent treatment plant in manufacturing unit; SOP-driven, GMP-compliant operations.